Aarti Pharmalabs Limited (NSE:AARTIPHARM)

India · Delayed Price · Currency is INR

681.05

-19.10 (-2.73%)

At close: Mar 9, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Pharmacuticals	21.15B	18.53B	19.45B	12.00B	-
Pharmacuticals Growth	14.17%	-4.76%	62.11%	-	-
Total	21.15B	18.53B	19.45B	12.00B	-
Total Growth	14.17%	-4.76%	62.11%	-	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
India	8.69B	7.82B	11.52B	-	-
India Growth	11.13%	-32.13%	-	-	-
Outside India	12.19B	10.36B	7.86B	-	-
Outside India Growth	17.62%	31.79%	-	-	-
Unallocated	273.76M	345.14M	69.74M	-	-
Unallocated Growth	-20.68%	394.88%	-	-	-
Total	21.15B	18.53B	19.45B	-	-
Total Growth	14.17%	-4.76%	-	-	-

Source: S&P Global Market Intelligence.